Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Thanks for your interest in this podcast. Please read this important program…
Thanks for your interest in this podcast. Please read this important program…
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
OcuTerra Therapeutics announced the topline results from its phase 2 DR:EAM (Diabetic…
In a study published in JAMA Ophthalmology, researchers from Oregon Health &…
In the period of Ramadan, a time when millions around the globe…
MediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the…
Researchers at the Broad Institute of MIT and Harvard have made a…
Vital Tears, known for its innovative autologous serum tears, is excited to…
Blindness and schizophrenia are two distinct conditions that, at first glance, may…
Neurolens announced the findings of a research study aimed at evaluating the…
Sandoz has successfully completed the acquisition of the United States biosimilar, Cimerli…
Enter your email address below and subscribe to our newsletter